INTERNATIONAL PATENT: KITE PHARMA, INC. FILES APPLICATION FOR "METHODS FOR GENERATING ENGINEERED LYMPHOCYTES WITH ENRICHED T MEMORY STEM CELLS"

GENEVA, Aug. 19 -- KITE PHARMA, INC. (2400 BroadwaySanta Monica, California 90404) filed a patent application (PCT/US2025/014572) for "METHODS FOR GENERATING ENGINEERED LYMPHOCYTES WITH ENRICHED T MEMORY STEM CELLS" on Feb 05, 2025. With publication no. WO/2025/170991, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERENT-MAOZ, Beata (Kite Pharma, Inc.,c/o Gilead Sciences, Inc., 333 Lakeside DriveFoster City, California 94404), LIU, Yijun (Kite Pharma, Inc.,c/o Gilead Sciences, Inc., 333 Lakeside DriveFoster City, Califo...